Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Modine Manufacturing
MOD
$10.6B
| $897K | ﹤0.01% |
73,500
-273,900
| -79% | -$3.41M |
|
|
TNH
2577
DELISTED
Terra Nitrogen
TNH
| $894K | ﹤0.01% |
9,100
-31,002
| -77% | -$3.18M |
|
2578
Scully Royalty
SRL
$90.9M
| $892K | ﹤0.01% |
100,203
-4,940
| -5% | -$49.7K |
|
|
BKEP
2579
DELISTED
Blueknight Energy Partners L.P.
BKEP
| $892K | ﹤0.01% |
132,094
+24,655
| +23% | +$173K |
|
2580
Madrigal Pharmaceuticals
MDGL
$12.4B
| $891K | ﹤0.01% |
57,875
+400
| +0.7% | +$6.29K |
|
2581
Global Partners
GLP
$1.72B
| $889K | ﹤0.01% |
45,609
-76,038
| -63% | -$1.51M |
|
|
IRS
2582
IRSA Inversiones y Representaciones
IRS
$1.24B
| $889K | ﹤0.01% |
37,668
-8,260
| -18% | -$177K |
|
|
LOAN
2583
Manhattan Bridge Capital
LOAN
$47.2M
| $889K | ﹤0.01% |
150,700
+21,200
| +16% | +$137K |
|
|
TULP
2584
Bloomia Holdings
TULP
$17.2M
| $885K | ﹤0.01% |
84,843
+229
| +0.3% | +$2.49K |
|
2585
Hennessy Advisors
HNNA
$78.9M
| $882K | ﹤0.01% |
52,450
-1,700
| -3% | -$31.3K |
|
|
MGP
2586
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $877K | ﹤0.01% |
+32,415
| New | +$831K |
|
|
GLUU
2587
DELISTED
Glu Mobile Inc.
GLUU
| $877K | ﹤0.01% |
+386,200
| New | +$834K |
|
|
GZT
2588
DELISTED
Gazit-globe Ltd
GZT
| $877K | ﹤0.01% |
83,800
+10,500
| +14% | +$104K |
|
2589
Oppenheimer Holdings
OPY
$1.23B
| $874K | ﹤0.01% |
51,136
-56,364
| -52% | -$974K |
|
|
RPRX
2590
DELISTED
Repros Therapeutics Inc.
RPRX
| $873K | ﹤0.01% |
727,113
+10,700
| +1% | +$13.4K |
|
|
MTLS
2591
Materialise
MTLS
$393M
| $869K | ﹤0.01% |
95,500
+23,200
| +32% | +$197K |
|
2592
Silicon Laboratories
SLAB
$7.3B
| $868K | ﹤0.01% |
11,798
-17,302
| -59% | -$1.21M |
|
2593
Xenon Pharmaceuticals
XENE
$6.31B
| $868K | ﹤0.01% |
217,090
+102,890
| +90% | +$809K |
|
|
AIFU
2594
AIFU Inc
AIFU
$218M
| $868K | ﹤0.01% |
251
+32
| +15% | +$112K |
|
|
QTS
2595
DELISTED
QTS REALTY TRUST, INC.
QTS
| $868K | ﹤0.01% |
+17,800
| New | +$893K |
|
|
PBT
2596
Permian Basin Royalty Trust
PBT
$1.56B
| $864K | ﹤0.01% |
92,427
-124,491
| -57% | -$1.11M |
|
|
USAP
2597
DELISTED
Universal Stainless & Alloy
USAP
| $862K | ﹤0.01% |
50,700
+1,900
| +4% | +$28.8K |
|
2598
TIM SA
TIMB
$8.69B
| $855K | ﹤0.01% |
53,500
-28,500
| -35% | -$427K |
|
|
MRTX
2599
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $854K | ﹤0.01% |
+164,302
| New | +$900K |
|
2600
Virco
VIRC
$95.5M
| $852K | ﹤0.01% |
215,600
-10,700
| -5% | -$44.6K |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.